Abstract:The original synthesis of dopamine in the laboratories of H.E. Dale in South London, followed some 50 years later by the seminal mapping of the mesencephalic dopamine (DA) pathways into ramifying mesostriatal, mesolimbic and mesocortical projections, the identification of several DA receptors and their signalling pathways, and the discovery of phasic and tonic modes of dopaminergic activity, have led to important questions about the functions of this modulatory neurotransmitter. The triadic division of these projections has suggested discrete and even parallel functions in movement (eg, Parkinson9s disease, dorsal striatum), reward (eg, drugs of abuse, nucleus accumbens) and cognition (eg, schizophrenia and attention deficit/hyperactivity disorder (ADHD), prefrontal cortex). However, several lines of evidence show that this division to be artificial, it also being important to consider interactions between prefrontal and striatal systems, between the various sectors of the striatum itself, and even its component “direct” and “indirect” pathways. This lecture will provide several examples of how work performed in experimental animals has informed these functional considerations, while also having profound implications for understanding the functions of dopamine in health and disease. A prime example is the discovery that prefrontal cortical dopamine modulates cognitive functions such as working memory, which our own work has suggested to be a consequence of stabilising representations of the world via dopamine D1 receptor actions. This contrasts with findings that striatal dopamine often serves to promote behavioural switching, as occurs for example in Parkinson9s disease, ADHD and stimulant abuse following dopaminergic therapy with l-dopa, methylphenidate, and a D2/3 agonist, respectively. The hypothesis that there exist optimal levels of dopamine activity for efficient cognitive functioning in the prefrontal cortex also has applicability in the sub-cortical brain, based for example on the discovery that optimal titration of dopaminergic therapy for motor function in Parkinson9s disease can lead, not only to cognitive enhancement, but also behavioural dysregulation in certain domains, possibly arising as a consequence of an “over-dosing” of ventral striatal dopamine pathways with probable motivational consequences. Such a motivational role is consonant with the discovery that rewarding effects of psychomotor stimulant drugs such as cocaine and amphetamine were mediated by dopamine-dependent functions of the nucleus accumbens in rats. Recent work has shown that addiction to such drugs is predicted by individual differences in the propensity for impulsive behaviour, associated with variations in dopamine receptor number in the ventral striatum. This impulsivity may reflect an aberrant engagement of pavlovian approach behaviour. However, work in animals has suggested that during the addictive process, there is a shift in control of drug-seeking behaviour from the ventral to dorsal striatum that is consistent with a role for dopamine in stimulus-response habit learning. Implications for recent findings in chronic drug abusers will also be discussed.

Responses of striatal neurons in the behaving monkey. 3. Effects of iontophoretically applied dopamine on normal responsiveness

Responses of Neurons in Different Regions of the Striatum of the Behaving Monkey

Responses of striatal neurons in the behaving monkey. 1. Head of the caudate nucleus

Dopaminergic Modulation of Neuronal Activity in the Monkey Putamen Through D1 and D2 Receptors During a Delayed Go/Nogo Task

Contrasting Effects of Excitotoxic Lesions of the Prefrontal Cortex on the Behavioural Response to D-Amphetamine and Presynaptic and Postsynaptic Measures of Striatal Dopamine Function in Monkeys

Effects of Dopamine-Receptor Blockade on Self-Stimulation in the Monkey

Functions of dopamine in the dorsal and ventral striatum

L-DOPA Treatment Modulates Nicotinic Receptors in Monkey Striatum.

Activity of neurons in the ventral tegmental region of the behaving monkey.

Responses of striatal neurons in the behaving monkey. 2. Visual processing in the caudal neostriatum.

Intracranial self-stimulation in orbitofrontal cortex and caudate nucleus of rhesus monkey: Effects of apomorphine, pimozide, and spiroperidol

Excitability of Dopamine Neurons: Modulation and Physiological Consequences

Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA.

An Observational Method for Quantifying the Behavioural Effects of Dopamine Agonists: Contrasting Effects of D-Amphetamine and Apomorphine.

Neuronal responses in the ventral striatum of the behaving macaque

Effects of Endogenous Dopamine on Two-State Voltage Oscillations of Striatum Medium Spiny Neurons

Dissociable Effects of Dopamine on Neuronal Firing Rate and Synchrony in the Dorsal Striatum

GL.01 Dopamine in Health and Disease

Dopaminergic action beyond its effects on motor function: imaging studies

Estimation of the transmission delays in the basal ganglia of the macaque monkey and subsequent predictions about oscillatory activity under dopamine depletion

Differential contributions of dopaminergic D1- and D2-like receptors to cognitive function in rhesus monkeys